4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-21-000083
Director sold 1,666 shares at an average $51.70 ($86,139)
From the SEC's structured data for this filing
Trades in this filing
SATO VICKI L · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-18 | Sale : show line 1 in the form | −806 | $51.26 | $41,316 | 132,025 | D |
| 2021-08-18 | Sale : show line 2 in the form | −860 | $52.12 | $44,823 | 131,165 | D |
| Open-market sales · 1,666 sh · avg $51.70 · $86,139 | ||||||
Loading xslF345X03/wf-form4_162949494285003.xml…